ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

期刊基本信息

  • 期刊名称:ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore)
  • 期刊ISSN:1540-658X
  • 期刊EISSN:1557-8127
  • 简称:ASSAY DRUG DEV TECHN
  • 影响因子:1.7
  • 实时影响因子:截止2025年5月19日:1.733
  • 五年影响因子:1.9
  • JCI期刊引文指标:0.41
  • h-index:52
  • 2024-2025自引率:0.00%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:http://www.liebertpub.com/forauthors/assay-and-drug-development-technologies/118/
  • 是否OA开放访问:No
  • 出版商:Mary Ann Liebert Inc.
  • 出版年份:2002

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Science Citation Index Expanded (SCIE)Scopus (CiteScore)

期刊介绍

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:
-Assay design, target development, and high-throughput technologies-
Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-
Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-
Approaches to assays configured for gene families, inherited, and infectious diseases-
Assays and strategies for adapting model organisms to drug discovery-
The use of stem cells as models of disease-
Translation of phenotypic outputs to target identification-
Exploration and mechanistic studies of the technical basis for assay and screening artifacts

投稿要求

  • 通讯方式:MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
  • 涉及的研究方向:医学-生化研究方法
  • 出版国家或地区:UNITED STATES
  • 出版语言:English
  • 年文章数:29
  • PubMed Central (PMC)链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1540-658X%5BISSN%5D
  • 平均录用比例:较易

CITESCORE

CiteScoreSJRSNIPCiteScore排名
3.300.3080.544
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
Q3103 / 156
34%
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Medicine
Q3131 / 177
26%

WOS期刊JCR分区

WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:BIOCHEMICAL RESEARCH METHODSSCIEQ466/86
23.8%
学科:PHARMACOLOGY & PHARMACYSCIEQ3256/352
27.4%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:BIOCHEMICAL RESEARCH METHODSSCIEQ472/86
16.86%
学科:PHARMACOLOGY & PHARMACYSCIEQ4266/353
24.79%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区4区1区
BIOCHEMICAL RESEARCH METHODS
生化研究方法
1区3区4区
PHARMACOLOGY & PHARMACY
药学
4区1区4区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 4区4区1区
BIOCHEMICAL RESEARCH METHODS
生化研究方法
1区2区4区
PHARMACOLOGY & PHARMACY
药学
4区4区4区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友